Recall Register

Food, drugs, devices › Elekta, Inc.

Device recall: MOSAIQ, an oncology information system used to manage workflows for treatment planning and delivery. It supports informa

FDA enforcement event 68355 · Class II · initiated 23 May 2014 · status Terminated · terminated 16 Jul 2021

DeviceVoluntary: Firm initiated1 product recordAtlanta, GA

Elekta, Inc. (Atlanta, GA) initiated this device recall on 23 May 2014; FDA lists 1 product record under event 68355, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 91% of the 1,176 device enforcement events initiated in 2014 carry the same class.

Status: Terminated, terminated 16 Jul 2021. Initiation: voluntary: firm initiated. Elekta, Inc. has 105 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Elekta, Inc., Atlanta, GA.

Reason for recall

"When using CMA, if the user hovers the mouse pointer exactly above the direction dropdowns and then uses the mouse thumbwheel or touchpad scroll bar, the direction selection might change when the intention was only to move the mouse to a different area of the screen."

Distribution

"Worldwide Distribution - USA (nationwide) including Puerto Rico, and the countries of Albania, Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-1800-2014MOSAIQ, an oncology information system used to manage workflows for treatment planning and delivery. It supports information flow among healthcare facility personnel and can be used wherever radiotherapy and/or chemotherapy are prescribed.723Class IITerminated25 Jun 2014

Context

91%of 2014 device events are Class II1,176 events that year
1product record in this eventfirm median: 1
105events on this register for the firm

Other enforcement events for Elekta, Inc.

InitiatedProduct (first record)TypeClassRecords
21 May 2026MOSAIQ Oncology Information SystemDeviceClass II1
3 Apr 2026Brand Name: Fletcher CT/MR Shielded Applicator Set Product Name: Intracavitary Remote Afterloading Applicator Product DeDeviceClass II3
19 Mar 2026Brand Name: Leksell Vantage Arc System REF: 1053958DeviceClass II1
18 Feb 2026Brand Name: Leksell Gamma Knife Product Description: Leksell Gamma Knife¿ Perfexion Leksell Gamma Knife¿ Icon" Leksell GDeviceClass II1
14 Dec 2025Brand Name: Elekta Medical Linear Accelerator Product Name: Elekta Synergy, Elekta Harmony, Elekta Infinity, Versa HD SoDeviceClass II1
12 Dec 2025Brand Name: Leksell GammaPlan Product Name: Radionuclide RT Treatment planning system Software Version: 11.1 Product DesDeviceClass II2
10 Dec 2025MOSAIQ Oncology Information System with Particle Therapy License (License Kit 45700000000IQRO)DeviceClass II1
30 Sep 2025Brand Name: Leksell Stereotactic System Product Name: Leksell Vantage Stereotactic System Software Version: n/a Product DeviceClass II1
15 Jan 2025MOSAIQ Oncology Information SystemDeviceClass II1
25 Oct 2023ELEKTA LIMITED Precise Digital Accelerator, REF MRT 6001, MRT 6011; Medical Charged-Particle Radiation Therapy System AcDeviceClass II6

All 105 events for Elekta, Inc.

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "When using CMA, if the user hovers the mouse pointer exactly above the direction dropdowns and then uses the mouse thumbwheel or touchpad scroll bar, the direction selection might change when the intention was only to move the mouse to a different area of the screen."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide Distribution - USA (nationwide) including Puerto Rico, and the countries of Albania, Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bosnia and Herzegovina,…"

Is the recall still ongoing?

FDA lists the status as Terminated; the termination date is 16 Jul 2021. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.